Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy

Xiaodong Yang(PhysioGenix (United States))
Critical Reviews in Oncology/Hematology
April 1, 2001
Cited by 459

Abstract


Related Papers

No related papers found

Powered by citation graph analysis